about
Optimal design of intervention studies to prevent influenza in healthy cohortsPandemic preparedness in Hawaii: a multicenter verification of real-time RT-PCR for the direct detection of influenza virus types A and B.Cost-benefit of stockpiling drugs for influenza pandemic.Oseltamivir in the management of influenza.From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?Predispensing of antivirals to high-risk individuals in an influenza pandemicAntiviral usage for H1N1 treatment: pros, cons and an argument for broader prescribing guidelines in the United States.Pre-dispensing of antivirals to high-risk individuals in an influenza pandemic.Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009.Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferretsUse of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United KingdomThe national pandemic flu service, oseltamivir, and a case of pancreatitis.Oseltamivir (tamiflu) induced depressive episode in a female adolescent.Oseltamivir: a clinical and pharmacological perspective.Economic Impact of a New Rapid PCR Assay for Detecting Influenza Virus in an Emergency Department and Hospitalized Patients.Viral Inhibition of Bacterial Phagocytosis by Human Macrophages: Redundant Role of CD36.Development of oseltamivir phosphonate congeners as anti-influenza agentsSubstrate-Competitive Activity-Based Profiling of Ester Prodrug Activating EnzymesEster-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers.Selectivity Improvement for Spectrofluorimetric Determination of Oseltamivir Phosphate in Human Plasma and in the Presence of Its Degradation Product.Use of Oseltamivir to control influenza complications after bone marrow transplantation.Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1.A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.Forsythoside A Controls Influenza A Virus Infection and Improves the Prognosis by Inhibiting Virus Replication in Mice.Detection and control of influenza outbreaks in well-vaccinated nursing home populations.Peramivir analogues bearing hydrophilic side chains exhibit higher activities against H275Y mutant than wild-type influenza virus.Photodegradation and inhibition of drug-resistant influenza virus neuraminidase using anthraquinone-sialic acid hybrids.synthesis and preliminary biologic evaluation of 5-substituted-2-(4-substituted phenyl)-1,3-benzoxazoles as a novel class of influenza virus A inhibitors.Barriers to positive policy change that aims to increase access to medicines through reclassification: the case of oseltamivir in New Zealand.Potential adverse effects of oseltamivir in rats: males are more vulnerable than females.Neuraminidase Inhibitors in Influenza Treatment and Prevention⁻Is It Time to Call It a Day?Phosphonate Congeners of Oseltamivir and Zanamivir as Effective Anti-influenza Drugs: Design, Synthesis and Biological ActivityPolyhydroxylated pyrrolidine and 2-oxapyrrolizidine as glycosidase inhibitorsSynthesis of oseltamivir and tamiphosphor from N-acetyl-d-glucosamineRP-HPLC Method for Determination of Oseltamivir Phosphate in Capsules and Spiked Plasma
P2860
Q28730583-69559A29-3282-41B0-906D-40BF47880EFDQ30227140-DBE054A2-C2F6-4F9F-962D-4A8E3826EAF6Q30351240-9C195CF3-A760-425A-94A9-D2AF3484B2F2Q30351736-1D240379-1EE9-4573-A0E7-48A054ED6B08Q30363724-31851BB1-5A9A-49FC-B547-347F9D14D732Q30383781-812C44B3-A59D-4C1D-8B89-29D4E53F6696Q30383811-2A0E556F-F12F-4A1C-8A58-19892DCAC9B5Q30385808-3B57961A-0FD1-4F40-98FF-58F40E9D0D2BQ30391598-D1CFC10A-43DA-43D8-BEF8-0F7C551BEFD8Q30403382-9714E31E-8A35-48C5-9D35-4ACD8B0918D5Q30404708-178413C6-1844-4ACD-AD80-226E2040128FQ30415146-394E579E-EF0D-4F6A-8FD3-0E5DA8463782Q34497585-15A0A525-D36C-4D78-AFDD-B69CCD8AF49FQ34515436-83BA6E04-3101-46F5-A1B7-0720D7100F81Q35898797-F014AD7F-9657-402C-B17B-DC366FD24DCDQ36152709-DC3FE7F1-E93D-4676-B1DC-C5FF27F2E6AFQ36382214-10B69FDB-07F5-4AAE-9ABF-67C07A9AFD8EQ36412505-50502064-8CFE-4A97-9AA9-028FF97F80FEQ37498914-31E25F1A-F96A-4F21-8221-E1A790C0B193Q37702261-6008DEC5-2228-49BA-B284-BE67C5C479A5Q38907869-C827D9EE-ABCB-4067-B923-9B1AAD956177Q39199981-F89A174E-5D01-4719-B3A9-AA6E43A32E64Q40106207-AA7D19C6-B6DE-489E-97F5-953E4D0BD93FQ40474661-1607203C-1869-4089-AFDD-E600E912DFD0Q40511008-6025F1A3-DEE5-4B1D-BE4B-D90AE691C7FCQ40693913-D9DE8F0A-5C9D-4672-BEB6-846E2118B732Q45051230-95B6BBEA-A0F1-4C33-92F1-84F39CF3A60DQ45324524-903B51B5-ED99-493F-828D-648E17A6BB32Q45353233-30EB4886-322B-498E-BF40-C66017C2661BQ45360109-DF09967D-35D8-42DA-B952-9A0EA68B6546Q47633940-A9CEB5A9-4F64-4022-AF20-749B4DD69DADQ51422981-070D3BCB-D247-413E-934B-5D6CA04419E1Q57093850-E6D0D68A-9D14-4CDF-ABDA-39B48281BE9FQ58239456-9F766672-01FE-472D-8646-E3E931D41FEEQ58239489-AB12550F-C600-4FF8-8692-5715E065BE03Q58239503-E2827D9C-0581-4A43-90FC-D8695F03C630Q58291504-32E0E7DB-7478-4612-A08B-6EB7D3D5D253
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oseltamivir: a review of its use in influenza.
@ast
Oseltamivir: a review of its use in influenza.
@en
Oseltamivir: a review of its use in influenza.
@nl
type
label
Oseltamivir: a review of its use in influenza.
@ast
Oseltamivir: a review of its use in influenza.
@en
Oseltamivir: a review of its use in influenza.
@nl
prefLabel
Oseltamivir: a review of its use in influenza.
@ast
Oseltamivir: a review of its use in influenza.
@en
Oseltamivir: a review of its use in influenza.
@nl
P1433
P1476
Oseltamivir: a review of its use in influenza.
@en
P2093
K McClellan
P304
P356
10.2165/00003495-200161020-00011
P577
2001-01-01T00:00:00Z
P6179
1012031970